Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
暂无分享,去创建一个
Daniel T. Fisher | A. Daud | H. Lyerly | J. Skitzki | A. Algazi | A. Mukhopadhyay | C. Twitty | Ravindra Gujar | Jon Salazar | Jack Y. Lee | Mian Han | E. Browning | D. Canton | Jun Zhang | Bianca Nguyen | Reneta Hermiz | Lauren Svenson